Keith R. Walley
Corporate Officer/Principal bei University of British Columbia
Profil
Keith R.
Walley was the founder of Cyon Therapeutics, Inc. (founded in 2014) and Sirius Genomics, Inc. (founded in 2001), where he held the title of Director.
He is currently a Professor at the University of British Columbia.
Dr. Walley received a doctorate degree from the University of Manitoba.
Aktive Positionen von Keith R. Walley
| Unternehmen | Position | Beginn |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Keith R. Walley
| Unternehmen | Position | Ende |
|---|---|---|
Cyon Therapeutics, Inc.
 Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada. | Gründer | 02.05.2014 |
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Gründer | - |
Ausbildung von Keith R. Walley
| University of Manitoba | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
Cyon Therapeutics, Inc.
Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada. | Commercial Services |